SPARK Ventures
VCs in $20m series-C extension for Tourlane
Tourism booking platform is backed by investors including Sequoia Capital and Spark Capital
Square buys VC-backed payment app Verse
Verse joins the Cash App division at Square and continues to operate as an independent business
Nordstjernan sells PriceRunner in management buy-back
Nordstjernan had owned PriceRunner since 2016, alongside Nicklas Storåkers and Karl‑Johan Persson
Spark Capital invests $15m in tablet startup Remarkable
Company plans to use the fresh capital to scale up its team and invest in product development
GoodWater Capital leads $30m series-B for Badi
Target Global and previous backers Spark Capital and Mangrove Capital also take part in the round
Kinnevik leads $44m series-C for TravelPerk
Previous backers including Felix Capital, Target Global and LocalGlobe also take part in the round
Spark Capital et al. back Tourlane
Consortium of VC firms take part in a €7m series-A round for German travel planning specialist Tourlane
Videregen raises £3.1m
Company has developed stem cell organ transplant technology
Spark et al. invest £1.5m in Cytox
UK-based biotech focuses on Alzheimer’s disease
VC-backed Oxford Immunotec raises $64m in IPO
UK-based medical diagnostics company Oxford Immunotec Global, which is backed by a consortium of investors, has listed on the Nasdaq with a market cap of $196.3m.
DFJ Esprit’s Oxford Immunotec to float
Oxford Immunotec Global, a UK-based medical diagnostics company, has filed with the US Security and Exchange Commission (SEC) for an IPO on the Nasdaq that would value the company at up to $245.4m.
PE-backed GetYourGuide acquires IGottaGuide
GetYourGuide, backed by Spark Capital and Highland Capital Partners (HCP), has bought IGottaGuide, a platform that connects tourists with local guides.
Spark backs Compliance Control with £110,000
Spark Impact has injected £110,000 into Compliance Control, a software company targeting the biomedical industry.
Spark backs Molplex with £350,000
Spark Impact has invested £350,000 into drug discovery company Molplex.
North West Fund backs Dot Medical
The North West Fund for Biomedical, managed by Spark Impact, has invested £550,000 in Dot Medical, which manufactures equipment to treat heart conditions.
Eden Ventures et al. exit WE7 to Tesco
Eden Ventures has sold its minority stake in Peter Gabriel’s digital music platform WE7 to retailer Tesco.
Spark backs Zilico with £750,000
Spark Ventures has injected £750,000 into Manchester-based cervical cancer diagnostics firm Zilico.
VCs in $28m funding round for Oxford Immunotec
A pool of venture capital firms has backed a $28m funding round for Oxford University’s medical diagnostics spin-off Oxford Immunotec.
notonthehighstreet.com receives £10m series-D funding
Fidelity Growth Partners Europe (FGPE) has joined previous investors Index Ventures and Greylock Partners in a £10m funding round for UK online business notonthehighstreet.com.